J. Coghlan

发表

Complex Challenges of Pulmonary Hypertension

J. Coghlan, 2012 .

Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study

H. Heinzl, U. Müller-Ladner, C. Denton, 2013, Annals of the rheumatic diseases.

Cardiac Involvement in Scleroderma

C. Denton, J. Coghlan, 2003 .

Safety and Efficacy of Ambrisentan in the Treatment of Pulmonary Arterial Hypertension

C. Valerio, J. Coghlan, Peter Kabunga, 2009 .

Bosentan in the treatment of pulmonary arterial hypertension with the focus on the mildly symptomatic patient

C. Valerio, J. Coghlan, 2009, Vascular health and risk management.

Cardiac assessment of patients for haematopoietic stem cell transplantation.

C. Handler, J. Coghlan, P. Kottaridis, 2007, Best practice & research. Clinical haematology.

Genetic determinants of risk and survival in pulmonary arterial hypertension

Lisa J. Martin, Ferhaan Ahmad, W. Ouwehand, 2018, bioRxiv.

Simplified method for compression of femoral false aneurysms.

C. Ilsley, N. Jepson, J. Coghlan, 1995, European heart journal.

Quartet of Unlikely Discoveries

J. Coghlan, 2005 .

Pulmonary thrombosis in Covid-19: before, during and after hospital admission

A. Drebes, L. Candilio, M. Vlachou, 2021, Journal of Thrombosis and Thrombolysis.

Results of an Expert Consensus Survey on the Treatment of Pulmonary Arterial Hypertension with Oral Prostacyclin Pathway Agents.

A. Frost, R. Krasuski, O. Sitbon, 2019, Chest.

Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension.

P. Corris, D. Kiely, R. Condliffe, 2008, American journal of respiratory and critical care medicine.

Genetic determinants of risk and survival in pulmonary arterial hypertension

Lisa J. Martin, Ferhaan Ahmad, W. Ouwehand, 2018, bioRxiv.

Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era.

P. Corris, D. Kiely, R. Condliffe, 2009, American journal of respiratory and critical care medicine.

Daily remote ischaemic conditioning following acute myocardial infarction: a randomised controlled trial

N. Samani, F. Lai, G. McCann, 2018, Heart.

Pulmonary artery aneurysms in Behçet's disease treated with anti-TNFα: A case series and review of the literature.

S. Sangle, E. Chan, J. Coghlan, 2016, Autoimmunity reviews.

Superior outcome with direct catheter laboratory access vs ED-activated primary percutaneous coronary intervention.

R. Rakhit, Colette Smith, C. Mavroudis, 2012, The American journal of emergency medicine.

Allopurinol pretreatment improves postoperative recovery and reduces lipid peroxidation in patients undergoing coronary artery bypass grafting.

T. Slater, C. Ilsley, J. Coghlan, 1994, The Journal of thoracic and cardiovascular surgery.

Evidence for the Involvement of Type I Interferon in Pulmonary Arterial Hypertension

M. Humbert, E. Fadel, J. Mitchell, 2014, Circulation research.

Two‐dimensional knowledge‐based volumetric reconstruction of the right ventricle documents short‐term improvement in pulmonary hypertension

C. Denton, D. Knight, B. Schreiber, 2017, Echocardiography.

Pretransplant clinicopathological correlation in end-stage primary pulmonary hypertension.

M. Yacoub, B. Madden, J. Gosney, 1994, The European respiratory journal.

Safety and feasibility audit of a home-based drug-transitioning approach for patients with pulmonary arterial hypertension: an observational study

B. Schreiber, J. Coghlan, J. Coghlan, 2018, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

Aggressive treatment of SSc-associated PAH by up-front combination therapy

J. Coghlan, 2018 .

Bochdalek hernia causing pulmonary hypertension.

B. Schreiber, D. Dobarro, J. Haddock, 2013, Circulation.

Balloon Pulmonary Angioplasty: State of the Art

S. Hoole, A. Rothman, J. Coghlan, 2020, Interventional cardiology.

Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: the UK experience

G. Martinez, M. Toshner, D. Taboada, 2020, Open Heart.

Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry.

K. Dimopoulos, J. Lordan, P. Corris, 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Postoperative hemodynamic improvement with paced linkage of the donor and recipient hearts following heterotopic cardiac transplantation

A. Khaghani, M. Yacoub, J. Morris-Thurgood, 1994, Clinical cardiology.

Connective tissue associated pulmonary arterial hypertension

C. Handler, J. Coghlan, JG Coghlan, 2006, Lupus.

Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis

C. Fischer, C. Denton, O. Distler, 2018, European Respiratory Journal.

Oral treatment with enoximone in patients referred for cardiac transplantation.

A. Mitchell, C. Ilsley, J. Coghlan, 1991, International journal of cardiology.

Clinical experience with bosentan and sitaxentan in connective tissue disease-associated pulmonary arterial hypertension.

C. Denton, C. Handler, Colette Smith, 2010, Rheumatology.

Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial

J. Barberà, H. Ghofrani, A. Frost, 2015, Annals of the rheumatic diseases.

Balloon pulmonary angioplasty: does it have a role in CTED?

J. Coghlan, 2018, Pulmonary circulation.

EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre study

K. Dimopoulos, A. Peacock, J. Yorke, 2020, European Respiratory Journal.

Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis

M. Kuwana, C. Blair, J. Langley, 2020, Annals of the Rheumatic Diseases.

Pulmonary Hypertension Associated with Connective Tissue Disease

J. Coghlan, J. Coghlan, H. Fayed, 2019, Seminars in Respiratory and Critical Care Medicine.

Stress echocardiography and Cochin Risk Prediction Score for the prediction of pulmonary arterial hypertension in scleroderma: not yet ready for prime time.

J. Coghlan, 2013, Arthritis and rheumatism.

Prognostic significance of computed tomography criteria for pulmonary veno-occlusive disease in systemic sclerosis-pulmonary arterial hypertension

B. Schreiber, D. Ridout, J. Haddock, 2017, Rheumatology.

Assessment of endpoints in pulmonary arterial hypertension associated with connective tissue disease

C. Denton, J. Pope, J. Coghlan, 2010, Current opinion in pulmonary medicine.

Chapter 13 - Cardiac Involvement in Scleroderma

C. Denton, J. Coghlan, 2017 .

Direct relationship between ischaemic burden and myocardial release of products of lipid peroxidation in patients undergoing percutaneous transluminal coronary angioplasty

T. Slater, A. Mitchell, V. Paul, 1994, Coronary artery disease.

Exercise pulmonary haemodynamics: a test in search of purpose

H. Bogaard, J. Coghlan, J. G. Coghlan, 2016, European Respiratory Journal.

Survival in pulmonary hypertension registries: the importance of incident cases.

P. Corris, D. Kiely, R. Condliffe, 2011, Chest.

Detection of free radicals and cholesterol hydroperoxides in blood taken from the coronary sinus of man during percutaneous transluminal coronary angioplasty.

T. Slater, A. Mitchell, C. Ilsley, 1991, Free radical research communications.

Reperfusion of infarcted tissue and free radicals

T. Slater, C. Ilsley, J. Coghlan, 1991, The Lancet.

Lipid peroxidation and changes in vitamin E levels during coronary artery bypass grafting.

T. Slater, C. Ilsley, J. Coghlan, 1993, The Journal of thoracic and cardiovascular surgery.

Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohort

U. Müller-Ladner, C. Denton, D. Khanna, 2017, Annals of the Rheumatic Diseases.

The Management of Duodenal Ulcer Relapse

C. O'Morain, A. Tobin, J. Coghlan, 1988 .

Scleroderma and breast implants.

D. D'cruz, S. Sangle, J. Coghlan, 2015, QJM : monthly journal of the Association of Physicians.

Cardiovascular magnetic resonance-guided right heart catheterization in a conventional CMR environment – predictors of procedure success and duration in pulmonary artery hypertension

V. Muthurangu, D. Knight, M. Fontana, 2019, Journal of Cardiovascular Magnetic Resonance.

An Update on the Evaluation and Management of Pulmonary Hypertension in Scleroderma

J. Coghlan, Ben Z. Schrieber, 2012, Current Rheumatology Reports.

CAMPYLOBACTER PYLORI AND RECURRENCE OF DUODENAL ULCERS— A 12-MONTH FOLLOW-UP STUDY

C. O'Morain, C. Dooley, C. Keane, 1987, The Lancet.

Dosage of colloidal bismuth subcitrate in duodenal ulcer healing and clearance of Campylobacter pylori

C. O'Morain, L. Hutchinson, C. Keane, 1990, Alimentary pharmacology & therapeutics.

Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis

Lisa J. Martin, Keith A. Marsolo, Ferhaan Ahmad, 2018, bioRxiv.

Cardiac involvement by lymphoma: diagnostic difficulties.

A. Mitchell, J. Coghlan, V. Paul, 1989, European heart journal.

Pulmonary hypertension in systemic lupus erythematosus.

B. Schreiber, J. Coghlan, J. Coghlan, 2013, Best practice & research. Clinical rheumatology.

The natriuretic peptides and their role in disorders of right heart dysfunction and pulmonary hypertension.

P. Timms, H. Ashrafian, D. Mukerjee, 2004, Clinical biochemistry.

Pulmonary Arterial Hypertension With Abnormal V/Q Single-Photon Emission Computed Tomography.

B. Schreiber, S. Ioannidis, Kenneth Chan, 2017, JACC. Cardiovascular imaging.

Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum.

S. Rosenkranz, M. Hoeper, K. Olsson, 2016, Journal of the American College of Cardiology.

Selexipag in the management of pulmonary arterial hypertension: an update

L. Clapp, C. Picken, J. Coghlan, 2019, Drug, healthcare and patient safety.

Cardiac Involvement: Evaluation and Management

Sanjiv J. Shah, J. Coghlan, J. Coghlan, 2017 .

Long‐Term Outcomes in Patients With Connective Tissue Disease–Associated Pulmonary Arterial Hypertension in the Modern Treatment Era: Meta‐Analyses of Randomized, Controlled Trials and Observational Registries

D. Khanna, S. Mathai, L. Chung, 2021, Arthritis & rheumatology.

Accuracy and Test-Retest Reproducibility of Two-Dimensional Knowledge-Based Volumetric Reconstruction of the Right Ventricle in Pulmonary Hypertension

V. Muthurangu, D. Knight, J. Davar, 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Accuracy and Reproducibility of Right Ventricular Quantification in Patients with Pressure and Volume Overload Using Single-Beat Three-Dimensional Echocardiography

M. Quail, A. Taylor, V. Muthurangu, 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

COVID-19 and the Heart: A Systematic Review of Cardiac Autopsies

Shroque Zaher, J. Coghlan, A. Roshdy, 2021, Frontiers in Cardiovascular Medicine.

Year : 2016 Pre-Capillary , Combined , and Post-Capillary Pulmonary Hypertension

K. Olsson, L. Scelsi, S. Ulrich, 2017 .

Anterior ST segment elevation due to isolated right ventricular infarction during right coronary angioplasty.

D. Lipkin, T. Koh, J. Coghlan, 1996, International Journal of Cardiology.

Adult Lead Toxicity and Untreated Coeliac Disease

C. O'Morain, J. Coghlan, 1988, Journal of the Royal Society of Medicine.

Is serodiagnosis of herpes simplex encephalitis safe?

J. Coghlan, C. Monaghan, P. A. Carney, 1987, Postgraduate medical journal.

Effects of paced counterpulsation on exercise capacity and hemodynamics after heterotopic heart transplantation.

A. Khaghani, M. Yacoub, J. Morris-Thurgood, 1995, The American journal of cardiology.

TCT CONNECT-221 Primary PCI for STEMI During the COVID-19 Pandemic in London: A Systematic Analysis of Pathway Activation and Outcomes

C. Little, R. Rakhit, G. Mikhail, 2020, Journal of the American College of Cardiology.

Vascular Health and Risk Management Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Bosentan in the Treatment of Pulmonary Arterial Hypertension with the Focus on the Mildly Symptomatic Patient

C. Valerio, J. Coghlan, 2022 .